promising cancer treatment It was successful in its first tests, so it could become the next method to fight cancerous tumors in the body.
This is a clinical trial published by a team of scientists from Columbia University in the journal Science Advances. According to the research, genetically modified bacteria they would be able to destroy tumors from the inside.
Bacteria do not pose any danger to humans. On the contrary, they are designed to send alerts to the immune systemdays to realize that there are cancer cells or developed tumors: in this way, the immune system will be able to prepare to attack this agent.
What does the Neptuno 100 project look like, for which the researcher will live for several months under the sea
In other words, the bacteria would act as a tumor locator, since they usually hide to avoid the immune system that wants to catch them.
Patients can receive the bacteria through the bloodstream or directly into the tumor. The goal is to prevent bacteria from reaching any other part of the body. In addition, chemokine molecules, “killer” T-cells and those that attract dendritic cells are activated.
The latter make the first attack on the foreign agent, and then take a fragment, known as an antigen, and expose it to other immune cells to detect it and come to their aid.
Although the treatment proposed by the Columbia scientists proved convincing in mice, The phase of human testing has not yet been reached., which would define whether the method is sustainable or not. If they prove successful in humans, the world of science and medicine could get their hands on a key treatment for this disease.
Bryan Ayala is a highly respected author and journalist, known for his in-depth reporting and analysis on healthcare issues. He currently works as an author at 247 news agency. With a background in medicine and a keen understanding of the complexities of the healthcare system, Bryan’s writing provides readers with a unique and informed perspective on the most pressing issues in healthcare today.